Safety and Efficacy of opioid-sparing Anesthesia Compared with Traditional opioid-anesthesia

医学 麻醉 类阿片 内科学 受体
作者
M. P. Lauretta,Luca Marino,Federico Bilotta
出处
期刊:The Clinical Journal of Pain [Lippincott Williams & Wilkins]
卷期号:41 (2)
标识
DOI:10.1097/ajp.0000000000001261
摘要

Objectives: The rationale of adoption opioid-sparing anesthesia (OSA) is to achieve perioperative analgesia with a minimal amount of opioids combined with nonopioid adjuvants during and after surgery, namely multimodal anesthesia. The OSA approach was originally developed to overcome the known complications of opioid-based anesthesia (OA), and the present scoping review (ScR) aims at providing clinical evidence of the safety and efficacy of OSA with respect to OA. Methods: This ScR is mainly focused on studies presenting evidence on the safety and efficacy of OSA versus OA. PubMed and EMBASE databases were utilized to find relevant studies. The search strategy included the following keywords: “opioid sparing anesthesia complications, opioid sparing anesthesia efficacy, opioid sparing anesthesia safety.” The findings from the 25 included studies were categorized into the following subsections: article characteristics, goals of the studies, OSA protocols, and surgical settings analyzed. Results: In the 25 reviewed studies, evidence related to the impact of OSA versus OA was considered. Intraoperative safety and efficacy end points include hemodynamic stability and anesthetic/analgesic requirements. Postoperative end points include early cognitive dysfunction, opioid-induced bowel disorder, the physical status of mothers and newborns after labor and emergency cesarean, systemic immune and inflammation modifications, postoperative recovery, in-hospital and long-term opioid requirement, early postoperative pain, and chronic postsurgical pain. The studies reported lower intraoperative mean arterial pressure and heart rate fluctuations when α 2 agonists were adopted, while no differences were recorded for other complication rates. Analysis of OSA approaches for the postoperative conditions includes α 2 agonists, NMDA receptor blocking agents, gabapentinoids, nefopam hydrochloride, and locoregional anesthesia techniques with a positive impact on most of the end points considered. Discussion: The clinical implementation of OSA encompasses the perioperative use of nonopioid drugs and locoregional anesthesia techniques. The reviewed studies reported OSA as a feasible approach to reduce opioid-related complications with no impact on patient safety.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
EVEN发布了新的文献求助10
刚刚
1秒前
侃侃发布了新的文献求助10
1秒前
1秒前
2秒前
快乐的向卉完成签到,获得积分10
2秒前
ps请好假了完成签到 ,获得积分10
2秒前
张先生发布了新的文献求助10
2秒前
mouxq发布了新的文献求助10
3秒前
勤劳元瑶完成签到,获得积分10
3秒前
3秒前
帅哥吴克发布了新的文献求助10
3秒前
4秒前
脑洞疼应助ZYP采纳,获得10
4秒前
英姑应助Ysk采纳,获得10
4秒前
4秒前
ps请好假了关注了科研通微信公众号
5秒前
可靠的老鼠完成签到,获得积分10
6秒前
文文文完成签到,获得积分10
6秒前
威武鸽子完成签到,获得积分10
6秒前
yanlan完成签到,获得积分10
6秒前
知来者发布了新的文献求助10
6秒前
饱满小鸽子关注了科研通微信公众号
7秒前
彭于晏应助林昭音采纳,获得10
7秒前
7秒前
7秒前
llllllllllll发布了新的文献求助10
8秒前
02完成签到,获得积分10
8秒前
萝卜的666发布了新的文献求助10
9秒前
蜂蜜完成签到,获得积分10
9秒前
XMUh完成签到,获得积分10
9秒前
杨建航完成签到,获得积分10
9秒前
善学以致用应助黄贺采纳,获得10
9秒前
mdjinij发布了新的文献求助10
9秒前
给室友灌尿催吐完成签到 ,获得积分10
9秒前
jeffery111发布了新的文献求助10
9秒前
sleepingfish发布了新的文献求助10
11秒前
11秒前
CipherSage应助梅狸猫不读博采纳,获得10
11秒前
传奇3应助罗勍采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Zeolites: From Fundamentals to Emerging Applications 1500
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
Hidden Generalizations Phonological Opacity in Optimality Theory 1000
Energy-Size Reduction Relationships In Comminution 500
Principles Of Comminution, I-Size Distribution And Surface Calculations 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4940082
求助须知:如何正确求助?哪些是违规求助? 4206266
关于积分的说明 13073713
捐赠科研通 3984859
什么是DOI,文献DOI怎么找? 2181904
邀请新用户注册赠送积分活动 1197544
关于科研通互助平台的介绍 1109846